Recent Updates
Recently added Catalysts

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real-time data to maximize your biotech profits.

yearly_arrow
Recommended
Elite Plus
For Serious Investors and Traders

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $29.00 per Month

Only $29.00/ Month

  • BiopharmaWatch AI analysis on every company page, updated when news breaks
  • 200 AI credits a month (1,000 a month on the annual plan) for custom research reports on any company, catalyst, or disease you choose
  • Alerts within minutes on your tickers: press releases, SEC filings, and catalyst date changes
  • Expected move into each catalyst, where the stock has listed options
  • All years of FDA history, pipeline value, every hedge fund quarter, and 3,000 download credits a month
  • Searchable FDA Calendar with 1,000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) scorecards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Recommended
Elite Plus
For Serious Investors and Traders

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $29.00 per Month

Only $29.00/ Month

  • BiopharmaWatch AI analysis on every company page, updated when news breaks
  • 200 AI credits a month (1,000 a month on the annual plan) for custom research reports on any company, catalyst, or disease you choose
  • Alerts within minutes on your tickers: press releases, SEC filings, and catalyst date changes
  • Expected move into each catalyst, where the stock has listed options
  • All years of FDA history, pipeline value, every hedge fund quarter, and 3,000 download credits a month
  • Searchable FDA Calendar with 1,000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) scorecards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Elite
For Explorers

Explore every biotech catalyst and discover why serious investors and traders choose Elite Plus.

Only $24.00/ Month

  • 1,000 AI credits a month on the annual plan; unused credits roll over until it renews
  • Searchable FDA Calendar with 1,000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) scorecards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
  • 300 download credits a month and the last 2 years of FDA history

Unlock the Full Potential with BPW Elite Plus

Free account: the next 6 FDA events, key PDUFA dates, market movers, and a news preview.

Features

Free Plan

Elite

Elite Plus

Recommended
Catalyst Calendars and Probability of Approval
PDUFA Calendar
Basic access to key PDUFA dates
Included
Full access to upcoming PDUFA dates, Probability of Approval (PoA), historical data with advanced filters, and insights into market-moving FDA decisions.
FDA Calendar
Limited access to the next 6 events
Included
Full access to clinical trial readouts from preclinical to Phase 3, PDUFA catalysts, top-line results, and regulatory milestones with PoA. Filter by therapeutic area or disease, and much more.
Probability of Approval (PoA)
Not included
Included
Detailed insights into the likelihood of drug approvals using historical trends and clinical performance metrics.
Historical FDA/PDUFA and Run-up or Run-down
Not included
Last 2 years only: historical PDUFA dates and clinical readouts from the past 2 years, with run-up and run-down analytics.
Full history: every historical PDUFA date and clinical readout, with run-up and run-down performance analytics and advanced filters to analyze past trends and outcomes.
Market Movers
Basic insights into top movers
Included
Comprehensive analysis of stocks impacted by FDA approvals, clinical data, and key catalysts.
BiopharmaWatch AI and Elite Plus
BiopharmaWatch AI Analysis
Not included
The analysis title and date on each company page.
An AI analysis on every company page, updated when a filing, catalyst or readout lands.
AI Credits
Not included
1,000 AI credits a month on the annual plan; unused credits roll over until it renews. Not included on the monthly plan.
200 AI credits a month, or 1,000 a month on the annual plan with roll-over, for custom research reports on any company, catalyst, or disease you choose.
Alerts Within Minutes
Not included
Not included
Alerts within minutes on your tickers: press releases, SEC filings, and catalyst date changes.
Expected Move
Not included
Not included
The expected move into each catalyst, where the stock has listed options.
Pipeline Value and M&A Scores
Not included
Not included
Pipeline score, rNPV, commercial value, and M&A target scores. PoA is in both plans.
Screener Formula Columns
Not included
Not included
Build your own formula columns in the Company Screener.
Earnings, Trials, and Conferences
Biotech Earnings Calendar
Not included
Included
Full access to all biotech earnings events, including historical EPS and financial trends.
Conference Calendar
Not included
Included
Full access to all biotech and pharma conferences, including schedules, presentations, and key updates.
Clinical Trial Quick Summary
Not included
Included
Concise summaries of trials, including phases, target conditions, and expected completion dates.
Research and Screening
Company Screener
Not included
Included
Comprehensive insights into company health, drug pipelines, financial metrics, and more.
CatalystSync™ Discovery and Filters
Not included
Included
Find actionable catalysts fast. Filter by phase, disease, price action, and liquidity; search tickers; save views; export to Excel; get alerts.
Positioning and Signals
Insider Trades
Not included
Included
Full insights into insider buying and selling activity for biotech and pharma stocks.
Hedge Fund Screener
Not included
Every quarter's roster of 45 biotech hedge funds, with each fund's holdings and activity for the last 2 years.
Full access to the holdings, strategies, and activity of 45 biotech hedge funds.
All Stock Holdings
Not included
Last 2 years only: the last 2 years of quarterly hedge fund and institutional holdings in each stock.
Every quarter since Q1 2021, with advanced filters to analyze hedge fund and institutional confidence in top biotech and pharma stocks.
Options Data and Strategies
Not included
Included
Options flow with strategy modules, including screeners and playbooks.
News, Alerts & Real-time Data
News and Alerts
Live news preview with basic alerts
Included
Live news feed with customizable alerts for tickers, drugs, and indications.
Real-time Market Data
Not included
Included
Real-time market updates, trends, and analysis.
Filters, Exports & Workflow
Advanced Filters and Saved Views
Basic filtering
Included
Powerful multi-select filters for phase, therapeutic area, catalyst window, fund activity, sentiment, and options signals with saved views.
Download Datasets in Excel
Not included
300 Download Credits a month (5,000 a year on the annual plan).
3,000 Download Credits a month. Download FDA or PDUFA catalysts, biotech profiles, conference schedules, insider trades, and all platform data with Download Credits for smarter investment decisions.
Support & Extras
Support
Community support
Email support
Priority email support for quick resolutions and assistance.
Education
Not included
Included
Exclusive courses on biotech investment basics.
Annual Bonus
Not included
Included with the annual plan
A quarterly 30-minute strategy call with the annual plan.

• Programmatic Access

Build with the BiopharmaWatch API

Access the entire BiopharmaWatch data platform directly from your code.
Power your quant models, trading systems, and research dashboards with institutional-grade biotech data.

Read the full API reference
/api/v2/fdacalendarUpcoming FDA catalyst events
/api/v2/pdufa/upcomingUpcoming PDUFA approval dates
/api/v2/pdufa/historicalPast PDUFA decisions & outcomes
/api/v2/catalystsyncCatalyst discovery & filtering
/api/v2/fdacalendar/historicalHistorical FDA calendar data
BiopharmaWatch API

For developers, quants, funds and data-driven investors: every BiopharmaWatch dataset through one API.

$99/month

Billed annually

  • Complete FDA calendar with upcoming clinical readouts and PDUFA dates
  • Probability of Approval (PoA) summary and deep scorecards
  • 5+ years of PDUFA data with decision outcomes and approval status
  • Historical catalyst data with price movements and key event metadata
  • Clinical-pipeline database, auto-updated across all monitored companies
  • SEC financial health: runway, burn, dilution and distress signals
  • Unusual-volume alerts, company universe, holders, gainers/losers
  • Company & pipeline scoring: risk-adjusted NPV (rNPV) and valuation signals
  • M&A target scores, deal tracker, and acquirer leaderboard
  • Pipeline health grades and competitive landscape intelligence
  • Hedge-fund positioning and insider-trading activity (Smart Money)
  • Conviction-weighted hedge-fund sentiment scores
  • Proprietary machine-learning clinical-trial results and risk signals
  • FDA designations, approvals and adverse-event safety signals
  • Options chain with Greeks, open interest and put-call analytics
  • JSON response format with secure API key authentication
  • 1,000 requests/min with full historical depth and priority support
  • Free setup consultation call for custom integration needs

Simple integration: just add your API key

GET https://api.biopharmawatch.com/api/v2/fdacalendar?apiKey=YOUR_KEY

• FAQs

The FDA Calendar lists upcoming biotech catalysts, including clinical readouts (preclinical through Phase 3), PDUFA decisions, top-line results, advisory committee dates, and key regulatory milestones. You can filter by therapeutic area, disease, stage, and timing, and set alerts so you never miss a window.

Yes. The dedicated PDUFA calendar shows upcoming FDA approval dates, changes, and outcomes. Elite Plus includes full historical PDUFA data with run-up and run-down analytics so you can study how price typically moves into and after decisions.

Catalyst data is manually updated twice daily, while the rest of the data, including real-time financials and market trends, is updated continuously throughout the day.

We use company press releases, SEC filings, clinical registries, investor decks, scientific publications, and conference posters and schedules. Each item is standardized so you can compare across companies.

PoA scorecards estimate the likelihood of approval using indication-specific base rates, trial design, and historical outcomes. Use PoA to compare risk-reward across assets and align position size to probability.

Yes. Elite and Elite Plus include Excel exports for FDA and PDUFA catalysts, company and pipeline profiles, conference schedules, insider trades, and other datasets to feed your models.

Yes. The API provides programmatic access to FDA events, PoA, historical catalysts, insider and hedge fund data, pipelines, and much more.

Yes, you can cancel anytime through your ‘My Subscription’ page. Simply click your profile picture in the top right menu. You can also reach out to us at contact@biopharmawatch.com for assistance.

Free is a preview only. Elite and Elite Plus unlock full coverage, alerts, PoA, options, exports, and more. Annual billing saves up to 26% and includes a quarterly 30-minute strategy call.

Elite follows every biotech catalyst: the full FDA and PDUFA calendars, company and drug pages with PoA, cash and runway, news, the screener, insider trades, and the watchlist email. Elite Plus adds BiopharmaWatch AI with 200 AI credits a month, alerts within minutes on your tickers, the expected move into each catalyst, all years of FDA history, pipeline value, every hedge fund quarter, and 3,000 download credits a month. Every annual plan, Elite or Elite Plus, carries 1,000 AI credits a month, and unused credits roll over until the plan renews.

Classic is the plan you have today: everything you have now, at your price. Nothing is taken away. Every Classic member gets 100 free AI credits to try BiopharmaWatch AI, Classic annual members get 1,000 AI credits a month that roll over until the plan renews, and anyone can move to Elite Plus at any time.
FAQ
Still Have Questions?

Can't find the answer you're looking for? Please chat with our friendly team.

See Why Professionals Choose BiopharmaWatch
Join 12,400+ investors who are already making profits

Since using BiopharmaWatch, my trades tied to biotech events have been 30% more successful. The FDA Calendar is like my secret weapon for timing the market always detailed and up-to date!

San Francisco, CA, USA

My portfolio is up 23% since I started using the Company Screener. It’s so easy to spot strong companies and avoid cash-burn disasters with the clear financial metrics provided!

Phoenix, AZ, USA

Integrating the API has improved our trading models by 25% with real time data on 200+ catalysts. It’s fast, accurate, and has saved us countless hours of manual work!

Munich, Germany

CatalystSync™ saves me hours weekly, tracking 50+ trials for my R&D projects. It’s intuitive, efficient, and has helped uncover trends I might have missed otherwise!

Chicago, IL, USA

We’ve already found three partnership opportunities this quarter thanks to CatalystSync™. The pipeline insights and market cap data give us a huge competitive edge!

London, UK

Using BiopharmaWatch, we’ve identified two companies with 40%+ returns this year. The PDUFA Calendar alone justifies the subscription-it’s incredibly detailed and actionable!

Boston, MA, USA

The portfolio tracking tools make managing my biotech investments so much smoother. Tracking catalysts and pipelines has helped me make better decisions that really pay off!

Berlin, Germany

The Hedge Fund Screener helped us align with top performing funds, boosting our portfolio by 15%. It’s like having insider knowledge of how major players shape their biotech strategies!

Toronto, Canada

Thanks to the searchable FDA Calendar and PDUFA catalysts, I’ve capitalized on key market moving events. This platform has been crucial for generating steady profits!

Boston, MA, USA

The research on over 1,100 companies and clinical trials is simply impressive. It’s helped shape more informed, strategic plans for both my investments and R&D work!

Nottingham, UK